活化血小板可杀灭金黄色葡萄球菌但不杀灭肺炎链球菌——FcγRIIa与PF4/肝素抗体的作用
本研究探讨PF4、抗PF4/肝素抗体及FcγRIIa在血小板杀伤革兰阳性菌中的作用。结果显示抗PF4/H抗体对血小板直接杀伤革兰阳性菌作用有限;金黄色葡萄球菌可被血小板或其释放物有效杀灭,而肺炎链球菌不被杀灭并影响血小板活性。
要点
- 血小板及其释放物可有效杀灭金黄色葡萄球菌,且不被PF4或抗PF4/H抗体增强。
- 阻断FcγRIIa对血小板杀灭金黄色葡萄球菌无影响。
- 肺炎链球菌不被血小板或释放物杀灭,反而导致血小板对TRAP-6刺激无反应并高表达PS。
核心结论
- 抗PF4/H抗体对血小板直接杀伤革兰阳性菌似乎仅起次要作用。
- 金黄色葡萄球菌可被血小板或血小板释放物杀灭。
- 肺炎链球菌不被杀灭,反而影响血小板活性。
研究设计与样本
- 采用流式细胞术检测PF4与蛋白A缺陷金黄色葡萄球菌(SA113Δspa)及无荚膜肺炎链球菌(D39Δcps)的结合及构象变化,使用单克隆(KKO、5B9)及患者来源抗PF4/H抗体。
- 通过菌落形成单位(cfu)计数量化血小板或血小板释放物孵育后的细菌杀伤。
- 使用流式细胞术分析血小板活化(CD62P表达、PAC-1结合)及磷脂酰丝氨酸(PS)暴露。
主要发现
- 单克隆及患者来源抗PF4/H抗体在PF4存在下与金黄色葡萄球菌和肺炎链球菌结合,荧光信号增加1.6倍(人抗PF4/H抗体)至24.0倍(KKO)。
- 金黄色葡萄球菌(5.5×10^4 cfu/mL)被血小板(2.7×10^4 cfu/mL)或释放物(2.9×10^4 cfu/mL)有效杀灭。
- PF4或抗PF4/H抗体未进一步增强杀伤;阻断FcγRIIa对血小板杀灭金黄色葡萄球菌无影响。
- 肺炎链球菌未被血小板或释放物杀灭;孵育后血小板对TRAP-6刺激无反应并暴露高水平PS。
临床怎么用
- 血小板及其释放物对金黄色葡萄球菌具有直接杀菌作用,提示血小板可能参与宿主防御。
- 抗PF4/H抗体在血小板杀伤革兰阳性菌中作用有限,HIT抗体与细菌防御的关系需进一步研究。
- 肺炎链球菌可导致血小板失活和PS暴露,临床感染时需关注血小板功能状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heparin induced thrombocytopenia (HIT) is likely a misdirected bacterial host defense mechanism. Platelet factor 4 (PF4) binds to polyanions on bacterial surfaces exposing neo-epitopes to which HIT antibodies bind. Platelets are activated by the resulting immune complexes via FcγRIIA, release bactericidal substances, and kill Gram-negative Escherichia coli. OBJECTIVES: To assess the role of PF4, anti-PF4/H antibodies and FcγRIIa in killing of Gram-positive bacteria by platelets. METHODS: Binding of PF4 to protein-A deficient Staphylococcus aureus (SA113Δspa) and non-encapsulated Streptococcus pneumoniae (D39Δcps) and its conformational change were assessed by flow cytometry using monoclonal (KKO,5B9) and patient derived anti-PF4/H antibodies. Killing of bacteria was quantified by counting colony forming units (cfu) after incubation with platelets or platelet releasate. Using flow cytometry, platelet activation (CD62P-expression, PAC-1 binding) and phosphatidylserine (PS)-exposure were analyzed. RESULTS: Monoclonal and patient-derived anti-PF4/H antibodies bound in the presence of PF4 to both S. aureus and S. pneumoniae (1.6-fold increased fluorescence signal for human anti-PF4/H antibodies to 24.0-fold increase for KKO). Staphylococcus aureus (5.5 × 104 cfu/mL) was efficiently killed by platelets (2.7 × 104 cfu/mL) or their releasate (2.9 × 104 cfu/mL). Killing was not further enhanced by PF4 or anti-PF4/H antibodies. Blocking FcγRIIa had no impact on killing of S. aureus by platelets. In contrast, S. pneumoniae was not killed by platelets or releasate. Instead, after incubation with pneumococci platelets were unresponsive to TRAP-6 stimulation and exposed high levels of PS. CONCLUSIONS: Anti-PF4/H antibodies seem to have only a minor role for direct killing of Gram-positive bacteria by platelets. Staphylococcus aureus is killed by platelets or platelet releasate. In contrast, S. pneumoniae affects platelet viability.
引用
- Wolff M, Handtke S, Palankar R, et al. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies. J Thromb Haemost. 2020. PMID: 32237268. doi:10.1111/jth.14814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。